Search Count: 12
 |
Crystal Structure Of Hiv Protease Complexed With (S)-N-(3-Fluoro-2-(2-(1-(Phenylsulfonyl)Piperazin-2-Yl)Ethyl)Phenyl)-3,3-Bis(4-Fluorophenyl)Propanamide
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.63 Å Release Date: 2018-01-03 Classification: VIRAL PROTEIN/INHIBITOR Ligands: CL, CKD |
 |
Crystal Structure Of Hiv Protease Complexed With N-(3-Fluoro-2-(2-((2S,6R)-6-Methyl-1-(Phenylsulfonyl)Piperazin-2-Yl)Ethyl)Phenyl)-3,3-Bis(4-Fluorophenyl)Propanamide
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.48 Å Release Date: 2018-01-03 Classification: VIRAL PROTEIN/INHIBITOR Ligands: CL, CKM |
 |
Crystal Structure Of Hiv Protease Complexed With N-(3-Fluoro-2-(2-((2S,6R)-6-Methyl-1-(Phenylsulfonyl)Piperazin-2-Yl)Ethyl)Phenyl)-3,3-Bis(4-Fluorophenyl)Propanamide
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2018-01-03 Classification: VIRAL PROTEIN/INHIBITOR Ligands: CL, CKS |
 |
Crystal Structure Of Hiv Protease Complexed With N-(3-Fluoro-2-(2-((2S,5S)-5-Methyl-1-(Phenylsulfonyl)Piperazin-2-Yl)Ethyl)Phenyl)-3,3-Bis(4-Fluorophenyl)Propanamide
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.46 Å Release Date: 2018-01-03 Classification: VIRAL PROTEIN/INHIBITOR Ligands: CL, CKV |
 |
Crystal Structure Of Hiv Protease Complexed With N-(3-Fluoro-2-(2-((2S,6S)-6-Methyl-1-(Phenylsulfonyl)Piperazin-2-Yl)Ethyl)Phenyl)-3,3-Bis(4-Fluorophenyl)Propanamide
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2018-01-03 Classification: VIRAL PROTEIN/INHIBITOR Ligands: CL, CKY |
 |
Crystal Structure Of Hiv Protease Complexed With N-(2-(2-((6R,9S)-2,2-Dioxido-2-Thia-1,7-Diazabicyclo[4.3.1]Decan-9-Yl)Ethyl)-3-Fluorophenyl)-3,3-Bis(4-Fluorophenyl)Propanamide
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.62 Å Release Date: 2018-01-03 Classification: VIRAL PROTEIN/INHIBITOR Ligands: CN4, CL |
 |
Organism: Xenopus laevis
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2014-07-16 Classification: Ligase/Ligase Inhibitor Ligands: 20Q, SO4 |
 |
Organism: Xenopus laevis
Method: X-RAY DIFFRACTION Resolution:1.14 Å Release Date: 2014-07-16 Classification: Ligase/Ligase inhibitor Ligands: 20U, SO4 |
 |
Organism: Xenopus laevis
Method: X-RAY DIFFRACTION Resolution:2.32 Å Release Date: 2014-07-02 Classification: Ligase/Ligase inhibitor Ligands: 20W, SO4 |
 |
The 1.9A Crystal Structure Of Humanized Xenopus Mdm2 With Ro5313109 - A Pyrrolidine Mdm2 Inhibitor
Organism: Xenopus laevis
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2013-07-24 Classification: LIGASE/LIGASE INHIBITOR Ligands: I09 |
 |
The 2.5A Crystal Structure Of Humanized Xenopus Mdm2 With Ro5316533 - A Pyrrolidine Mdm2 Inhibitor
Organism: Xenopus laevis
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2013-07-24 Classification: LIGASE/LIGASE INHIBITOR Ligands: 1OY |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2006-10-10 Classification: TRANSFERASE Ligands: LIA |